Kisspeptin-10 — GPR54 (KISS1R) Agonist | Decapeptide GnRH Pulse-Generator Research Compound
Research-Grade Compound
Kisspeptin-10 (KP-10) is the 10-amino-acid C-terminal fragment of kisspeptin, the peptide product of the KISS1 gene, and acts as an agonist at GPR54 — the G protein-coupled receptor also designated KISS1R. Sequence: Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2 (YNWNSFGLRF-NH2). Molecular formula C63H83N17O14, molecular weight 1,302.5 Da, CAS 374675-21-5.
Select Size
This Certificate of Analysis was issued by an independent third-party laboratory. Peptide.Express does not conduct in-house testing. Results are provided as-is from the testing facility and confirm batch identity, purity, and analytical methodology. For questions about specific CoA results, contact [email protected].
What is Kisspeptin-10?
Kisspeptin-10 (KP-10) is the 10-amino-acid C-terminal fragment of kisspeptin, the peptide product of the KISS1 gene, and acts as an agonist at GPR54 — the G protein-coupled receptor also designated KISS1R. Sequence: Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2 (YNWNSFGLRF-NH2). Molecular formula C63H83N17O14, molecular weight 1,302.5 Da, CAS 374675-21-5.
The compound has two research literatures that barely speak to each other. KISS1 was first characterised as a metastasis-suppressor gene in melanoma cells, and its product was named metastin on that basis. The reproductive function arrived later and from a different direction entirely — loss-of-function mutations in GPR54 were linked to hypogonadotropic hypogonadism, which established the receptor as the gate on the hypothalamic-pituitary-gonadal axis. One gene, one receptor, two fields that still cite each other sparingly.
Kisspeptin circulates as several processed forms — kisspeptin-54, -14, -13 and -10 — all sharing the same C-terminal decapeptide and the RF-amide terminus that the receptor recognises. KP-10 is the shortest form retaining full receptor activity, which is why it became the standard tool compound rather than the full-length peptide. The C-terminal amide is not optional: remove it and receptor binding falls off sharply.
How Does Kisspeptin-10 Work? Mechanism of Action
GPR54 couples to Gq/11 rather than Gs, which sets kisspeptin apart from most of the neuroendocrine compounds in this catalog. Receptor activation engages phospholipase C beta, which hydrolyses PIP2 into inositol trisphosphate and diacylglycerol. IP3 releases calcium from intracellular stores; DAG activates protein kinase C. The calcium transient, together with membrane depolarisation, drives vesicular GnRH release from the neuron.
That GnRH enters the hypophyseal portal circulation and acts on pituitary gonadotrophs, which secrete luteinising hormone and follicle-stimulating hormone. LH and FSH then drive gonadal steroidogenesis and gametogenesis. Kisspeptin sits one step upstream of the entire cascade — which is precisely why it is described as the gate on the HPG axis rather than one input among several.
The neuroanatomy carries most of the interesting detail. In the arcuate nucleus, kisspeptin neurons co-express neurokinin B and dynorphin — the KNDy population — and this group is the leading candidate for the GnRH pulse generator itself, with neurokinin B providing the excitatory drive and dynorphin the inhibitory brake that together set pulse frequency. A second population in the anteroventral periventricular nucleus is associated with the preovulatory surge in rodents. Human hypothalamic anatomy does not map cleanly onto the rodent nuclei, and translating between the two is an active methodological problem rather than a solved one.
One practical caution for study design: GPR54 desensitises under continuous agonist exposure. Bolus administration and constant infusion of the same compound can produce opposite readouts on LH output, because sustained receptor occupancy downregulates the very signalling the experiment is trying to measure. Protocols reporting a kisspeptin effect on gonadotropin secretion without specifying the exposure pattern are underspecified.
Research Applications of Kisspeptin-10
HPG Axis and Gonadotropin Regulation
- LH pulse frequency studies: kisspeptin administration is the standard way to probe pulse generator output in reproductive neuroendocrinology models.
- GnRH neuron electrophysiology: patch-clamp recording of depolarisation and firing rate after GPR54 activation links receptor signalling directly to neuronal output.
- Gonadotroph responsiveness: separating hypothalamic from pituitary contributions requires a design that stimulates upstream with kisspeptin and downstream with GnRH in the same preparation.
GPR54 Receptor Pharmacology
- Gq/11-PLC-IP3 calcium mobilisation assays: intracellular calcium flux in KISS1R-expressing cell lines is the direct in-vitro readout of receptor activation.
- Desensitisation kinetics: continuous versus pulsatile exposure produces divergent receptor behaviour, and characterising that divergence is a research question in its own right.
- Fragment structure-activity work: comparing KP-10 against longer processed forms and against C-terminally modified analogs isolates the contribution of the RF-amide terminus.
KISS1 Metastasis-Suppressor Research
- Cell migration and invasion assays: the original KISS1 phenotype was suppression of metastatic behaviour in melanoma lines, and transwell migration remains the standard endpoint.
- Matrix metalloproteinase regulation: MMP-9 downregulation is among the more consistently reported downstream effects in the oncology literature.
- Cross-literature reconciliation: the reproductive and metastasis-suppression fields describe the same receptor with little overlap in method or model, which is itself worth noting when designing studies that draw on both.
Kisspeptin-10 vs Kisspeptin-54
| Feature | Kisspeptin-10 (KP-10) | Kisspeptin-54 (metastin) |
|---|---|---|
| Identity | C-terminal decapeptide fragment | Full-length processed KISS1 gene product |
| Amino acid count | 10 | 54 |
| Sequence | YNWNSFGLRF-NH2 | Contains the same C-terminal decapeptide |
| Receptor | GPR54 / KISS1R | GPR54 / KISS1R |
| Receptor-binding element | C-terminal RF-amide | Same C-terminal RF-amide |
| Reported plasma persistence | Shorter — cleared rapidly | Longer-lasting in circulation |
| Typical research use | Acute pulse and receptor-activation studies | Sustained-exposure and longer-duration designs |
| Molecular weight | 1,302.5 Da (LC-MS/MS confirmed) | Substantially larger — verify against supplier CoA |
| Peptide.Express availability | Supplied as lyophilized powder | Not currently supplied |
Both forms hit the same receptor through the same RF-amide terminus, so the choice between them is a pharmacokinetic decision rather than a pharmacological one. KP-10 is cleared faster, which makes it the better fit for acute pulse work and the worse fit for anything requiring sustained receptor occupancy — and since GPR54 desensitises under sustained occupancy, that trade-off is not simply a matter of dosing frequency.
Kisspeptin-10 Technical Specifications
| Compound Name | Kisspeptin-10 (KP-10) |
|---|---|
| Common Synonyms | Kisspeptin 10, Kiss-10, KP-10, metastin fragment 45-54 |
| Classification | RF-amide decapeptide, GPR54 (KISS1R) agonist |
| Gene of Origin | KISS1 |
| Receptor Target | GPR54, also designated KISS1R |
| Receptor Coupling | Gq/11 — phospholipase C, IP3, intracellular calcium release |
| Amino Acid Sequence | Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2 (YNWNSFGLRF-NH2) |
| Amino Acid Count | 10 (decapeptide) |
| C-Terminus | Amidated — required for receptor binding |
| CAS Number | 374675-21-5 |
| Molecular Formula | C63H83N17O14 |
| Molecular Weight | 1,302.5 Da |
| Purity | ≥99% by HPLC |
| Purity Confirmation | LC-MS/MS molecular weight verification |
| Endotoxin Testing | LAL (Limulus Amebocyte Lysate) method |
| Physical Form | Lyophilized powder |
| Appearance | White to off-white powder |
| Reconstitution | Bacteriostatic water or sterile 0.9% sodium chloride |
| Storage (lyophilized) | -20°C, desiccated, protected from light |
| Storage (reconstituted) | 2–8°C, use within 14–28 days |
| Shelf Life | 24 months from manufacture (lyophilized) |
| Testing Methods | HPLC, LC-MS/MS, LAL Endotoxin |
| Documentation | Certificate of Analysis (CoA) per batch |
| FDA Status | Not approved for human use |
| Intended Use | In-vitro laboratory research only |
How to Reconstitute Kisspeptin-10 for Research
Kisspeptin-10 contains tryptophan at position 3, and tryptophan-containing peptides are more light-sensitive than most. Keep the reconstituted vial protected from light rather than leaving it on an open bench between draws.
- Bring the vial to room temperature before opening.
- Draw the calculated volume of bacteriostatic water. For a 5 mg vial, 2.5 mL yields 2 mg/mL and 1 mL yields 5 mg/mL.
- Swab the septum with alcohol and allow 30 seconds to dry.
- Inject the diluent slowly down the inner vial wall rather than onto the lyophilized cake.
- Swirl gently for 60–90 seconds until fully dissolved. Do not shake or vortex.
- Confirm the solution is clear and colorless with no visible particulate matter.
- Label with the reconstitution date and concentration, and return the vial to light-protected refrigerated storage promptly.
- Store at 2–8°C and use within 14–28 days. Avoid repeated freeze-thaw cycles.
Diluent: bacteriostatic water for peptide reconstitution. Full protocol: step-by-step peptide reconstitution guide. Concentration maths: peptide reconstitution calculator.
Frequently Asked Questions — Kisspeptin-10
What is kisspeptin?
What receptor does kisspeptin activate, and how?
What is the role of kisspeptin in GnRH regulation?
What is the HPG axis?
What are KNDy neurons?
What is the difference between kisspeptin-10 and kisspeptin-54?
Is kisspeptin related to the KISS1 metastasis suppressor gene?
Can kisspeptin-10 be used in LH pulse research?
Why does kisspeptin-10 need an amidated C-terminus?
What purity standard and testing does Peptide.Express apply to Kisspeptin-10?
How should Kisspeptin-10 be stored before and after reconstitution?
Where is the Certificate of Analysis for Kisspeptin-10?
Research References
- Han SK, Gottsch ML, Lee KJ, Popa SM, Smith JT, Jakawich SK, Clifton DK, Steiner RA, Herbison AE. Activation of gonadotropin-releasing hormone neurons by kisspeptin as a neuroendocrine switch for the onset of puberty. J Neurosci. 2005. Read Han et al. on kisspeptin-evoked depolarization of GnRH neurons
- de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A. 2003. Read de Roux et al.'s identification of GPR54 loss-of-function hypogonadotropic hypogonadism
- Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, Welch DR. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst. 1996. Read Lee et al.'s identification of KiSS-1 as a melanoma metastasis suppressor
All products are sold for in-vitro laboratory research use only. Not intended for human consumption, clinical use, or veterinary use. Peptide.Express makes no medical claims. Consult the published literature for research application guidance.